How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

100 results for

Denver Developmental Screening Test II

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. General Recommendations for the Care of Homeless Patients

) • Developmental assessment - Ages & Stages Questionnaires, Parents’ Evaluation of Develop- mental Status (PEDS), Denver II or other standard screening tool • Interpersonal violence - Posttraumatic Diagnostic Scale for Use with Extremely Low-income Women • Forensic evaluation - if strong evidence of child abuse • Health care maintenance - cancer screening for adults, EPSDT for children PLAN & MANAGEMENT Plan of care • Basic needs - Food, clothing, housing may be higher priorities than health care. • Patient (...) living in shelters and others at risk for tuberculosis; QuantiFERON®-TB Gold test (QFT-G) if available • STI screening - for chlamydia, gonorrhea, syphilis, HIV, HBV, HCV, trichomonas, bacterial vagino- sis, monilia • Mental health - Patient Health Questionnaire (PHQ-9, PHQ-2), MHS-III, MDQ • Substance abuse - SSI-AOD • Cognitive assessment - Mini-Mental Status Examination (MMSE), Traumatic Brain Injury Ques- tionnaire (TBIQ), Repeatable Battery for the Assessment of Neuro-Psychological Status (RBANS

2010 National Health Care for the Homeless Council

62. Facioscapulohumeral Dystrophy in Children

] Walking Distance in 6 minutes. ICH Body functioning: Denver II developmental screening test [ Time Frame: 2 years ] Developmental level. ICH Body functioning: visual acuity [ Time Frame: 2 years ] Snellen card ICH Body functioning: hearing [ Time Frame: 2 years ] Tone- and voice audiometry ICH Body functioning: mental functioning [ Time Frame: 2 years ] Electro-encephalography performed in clinically suspected epilepsy. ICH Body functioning: Pain [ Time Frame: 2 years ] Faces scale pain. ICH Body (...) muscle weakness, pain, fatigue, epilepsy, hearing loss, vision loss, mental retardation and spinal deformities. The prevalence of these symptoms and the adequate follow-up of these symptoms is unknown. Moreover the clinical impact and social functioning of children with FSHD is under exposed. Therefore this study will focus on the total spectrum of FSHD in children. In addition, an extensive genetic screening will be conducted, searching for (epi)genetic disease modifiers and severity predictors

2015 Clinical Trials

63. Mindfulness-Based Cognitive Therapy for the Prevention of Perinatal Depressive Relapse/Recurrence

group will receive "ongoing assessment and referral" (OAR), consisting of routine screening and referral to behavioral health services within obstetric clinical settings within Kaiser Permanente (KP) in Colorado and Georgia. The investigators will randomly assign participants at each site to 8 weeks of MBCT-PD or OAR. During this phase, the investigators will address the following aims: Specific Aim 1: To test the primary hypothesis that participants receiving MBCT-PD will experience improved (...) in the context of pregnancy and in anticipation of the postpartum. Active Comparator: OAR Ongoing Assessment and Referral (OAR) Behavioral: OAR Ongoing Assessment and Referral (OAR) consists of routine screening and referral to behavioral health services within obstetric clinical settings within Kaiser Permanente (KP) in Colorado and Georgia. Outcome Measures Go to Primary Outcome Measures : Engagement (class attendance) [ Time Frame: Up to 8 weeks ] Engagement is operationalized in-part as class attendance

2015 Clinical Trials

64. Pregnancy after Bariatric Surgery: Obstetric and Perinatal Outcomes and the Growth and Development of Children. (PubMed)

was 64.88. Speech delays were found in three male children evaluated using the Denver Developmental Screening Test II. A statistical association was found between the interval from the surgery to the pregnancy and the outcome of the questionable Denver II test results (p = 0.011).Except for the large index of low birth weight, it can be concluded that pregnancy after bariatric surgery is safe. The growth rate was found to be adequate in the children born after the surgery, with reduced obesity. Although

2015 Obesity Surgery

65. Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study. (PubMed)

. Neurologic evaluations and Denver Developmental Screening Test II were performed at 6 months.Compared with healthy neonates, the two HIE groups had increased melatonin, SOD and NO. At enrollment, the two HIE groups did not differ in clinical, laboratory or EEG findings. At 5 days, the melatonin/hypothermia group had greater increase in melatonin (P<0.001) and decline in NO (P<0.001), but less decline in SOD (P=0.004). The melatonin/hypothermia group had fewer seizures on follow-up EEG and less white (...) matter abnormalities on MRI. At 6 months, the melatonin/hypothermia group had improved survival without neurological or developmental abnormalities (P<0.001).Early administration of melatonin to asphyxiated term neonates is feasible and may ameliorate brain injury.

2015 Journal of perinatology : official journal of the California Perinatal Association Controlled trial quality: uncertain

66. Trial of Therapeutic Horseback Riding in Children and Adolescents With Autism Spectrum Disorder

: One month pre-intervention, weekly for 10 weeks during intervention, and one month post intervention, and 6 months post intervention ] Subjects in the THR group will have greater improvement on communication, as measured by blinded speech therapist assessment using the Peabody Picture Vocabulary Test and the Systematic Analysis of Language Transcripts, as well as by parent interview utilizing the Vineland Adaptive Behavior Scales-II communication subscale, than the control group. Change (...) the Peabody Picture Vocabulary Test and the Systematic Analysis of Language Transcripts, as well as by parent interview utilizing the Vineland Adaptive Behavior Scales-II communication subscale. Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research

2014 Clinical Trials

67. Melatonin for Neuroprotection Following Perinatal Asphyxia

] Incidence of abnormal Denver Developmental Screening Test II [ Time Frame: 6 months ] Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Layout table for eligibility information (...) Screening Test II assessments were performed at 6 months. A group of healthy newborns will be used as a control for baseline labs. Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 45 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: Triple (Participant, Investigator, Outcomes Assessor) Primary Purpose: Treatment Official Title: Melatonin for Neuroprotection Following Perinatal Asphyxia Study Start

2014 Clinical Trials

68. Genetics of Skin Cancer

decisions about genetic testing for inherited cancer risk and risk-management strategies. for pathogenic variants in CDKN2A is generally high. Perceived benefits among individuals with a strong family history of melanoma include information about the risk of melanoma for themselves and their children and increased motivation for sun-protective behavior. A number of studies have examined in individuals with a family history of melanoma. Overall, these studies indicate inconsistent adoption (...) and maintenance of these behaviors. Intervention studies have targeted knowledge about melanoma, sun protection, and screening behaviors in family members of melanoma patients, with mixed results. Research is ongoing to better understand and address psychosocial and behavioral issues in high-risk families. Introduction [ Note: Many of the medical and scientific terms used in this summary are found in the . When a linked term is clicked, the definition will appear in a separate window. ] [ Note: A concerted

2012 PDQ - NCI's Comprehensive Cancer Database

69. Autistic Spectrum Disorders (Overview)

fill out the Autism Screening Checklist can identify children who merit further assessment for possible autism. See the image below for a printable version of the checklist. The significance of answers to individual Autism Screening Checklist items is as follows: Item 1- A "yes" occurs in healthy children and children with some pervasive developmental disorders; a "no" occurs in children with autism, Rett syndrome, and other developmental disorders. Item 2 - A "yes" occurs in healthy children (...) -by-case basis. (See Treatment.) Practice guidelines The American Academy of Child and Adolescent Psychiatry's practice guidelines for the assessment and treatment of children and adolescents with ASD include the following recommendations: [ , ] Questions about core symptoms of ASD should be a routine part of psychiatric and developmental assessments of young children. If screening reveals significant ASD symptomatology, a thorough evaluation should be performed and possible comorbid diagnoses should

2014 eMedicine.com

70. Status Epilepticus (Diagnosis)

screening and anticonvulsant drug levels Arterial blood gas results Other tests that may be appropriate depending on the clinical setting include the following: Electroencephalography: Criterion standard for diagnosing status epilepticus [ , ] ; however, neurologic consultation is usually required Blood cultures Urinalysis and/or cerebrospinal fluid analysis Imaging studies Imaging modalities used to evaluate status epilepticus may include the following: CT scanning and/or MRI of the brain Chest (...) subdividing it into type I (nonprogressive) and type II (progressive). Type I epilepsy partialis continua features include the following: Intermittent, semi-rhythmic, involuntary twitching involving a discrete subset of muscles Most commonly affects the face and ipsilateral distal hand musculature Myoclonus of this variety may evolve into partial or generalized convulsion Type II epilepsy partialis continua features include the following: Usually linked with Rasmussen encephalitis Gradual loss

2014 eMedicine.com

71. Focal Status Epilepticus (Diagnosis)

screening and anticonvulsant drug levels Arterial blood gas results Other tests that may be appropriate depending on the clinical setting include the following: Electroencephalography: Criterion standard for diagnosing status epilepticus [ , ] ; however, neurologic consultation is usually required Blood cultures Urinalysis and/or cerebrospinal fluid analysis Imaging studies Imaging modalities used to evaluate status epilepticus may include the following: CT scanning and/or MRI of the brain Chest (...) subdividing it into type I (nonprogressive) and type II (progressive). Type I epilepsy partialis continua features include the following: Intermittent, semi-rhythmic, involuntary twitching involving a discrete subset of muscles Most commonly affects the face and ipsilateral distal hand musculature Myoclonus of this variety may evolve into partial or generalized convulsion Type II epilepsy partialis continua features include the following: Usually linked with Rasmussen encephalitis Gradual loss

2014 eMedicine.com

72. Focal Status Epilepticus (Overview)

screening and anticonvulsant drug levels Arterial blood gas results Other tests that may be appropriate depending on the clinical setting include the following: Electroencephalography: Criterion standard for diagnosing status epilepticus [ , ] ; however, neurologic consultation is usually required Blood cultures Urinalysis and/or cerebrospinal fluid analysis Imaging studies Imaging modalities used to evaluate status epilepticus may include the following: CT scanning and/or MRI of the brain Chest (...) subdividing it into type I (nonprogressive) and type II (progressive). Type I epilepsy partialis continua features include the following: Intermittent, semi-rhythmic, involuntary twitching involving a discrete subset of muscles Most commonly affects the face and ipsilateral distal hand musculature Myoclonus of this variety may evolve into partial or generalized convulsion Type II epilepsy partialis continua features include the following: Usually linked with Rasmussen encephalitis Gradual loss

2014 eMedicine.com

73. Status Epilepticus (Overview)

screening and anticonvulsant drug levels Arterial blood gas results Other tests that may be appropriate depending on the clinical setting include the following: Electroencephalography: Criterion standard for diagnosing status epilepticus [ , ] ; however, neurologic consultation is usually required Blood cultures Urinalysis and/or cerebrospinal fluid analysis Imaging studies Imaging modalities used to evaluate status epilepticus may include the following: CT scanning and/or MRI of the brain Chest (...) subdividing it into type I (nonprogressive) and type II (progressive). Type I epilepsy partialis continua features include the following: Intermittent, semi-rhythmic, involuntary twitching involving a discrete subset of muscles Most commonly affects the face and ipsilateral distal hand musculature Myoclonus of this variety may evolve into partial or generalized convulsion Type II epilepsy partialis continua features include the following: Usually linked with Rasmussen encephalitis Gradual loss

2014 eMedicine.com

74. Cri-du-chat Syndrome (Treatment)

the Denver Developmental Screening Test II. [ ] Next: Surgical Care See the list below: Correction of congenital heart defects may be indicated. Medical problems involving minor malformations such as strabismus and clubfoot may be amenable to surgical correction. Orchiopexy may be necessary in patients with undescended testes. Issues important to anesthetic plan include the following: Anatomical abnormalities of the airway Congenital heart disease Hypotonia Mental retardation Temperature maintenance (...) Previous Next: Consultations See the list below: Clinical geneticist Developmental pediatrician Neurologist Cardiologist Ophthalmologist Dentist Orthopedist Psychologist Physical and occupational therapist Speech language pathologist Audiologist Urologist Previous Next: Diet See the list below: No special diet is required. Previous Next: Activity See the list below: Activities are limited in patients with profound mental retardation and physical limitations. Previous References LeJeune J. [Role

2014 eMedicine Pediatrics

75. Status Epilepticus (Diagnosis)

screening and anticonvulsant drug levels Arterial blood gas results Other tests that may be appropriate depending on the clinical setting include the following: Electroencephalography: Criterion standard for diagnosing status epilepticus [ , ] ; however, neurologic consultation is usually required Blood cultures Urinalysis and/or cerebrospinal fluid analysis Imaging studies Imaging modalities used to evaluate status epilepticus may include the following: CT scanning and/or MRI of the brain Chest (...) subdividing it into type I (nonprogressive) and type II (progressive). Type I epilepsy partialis continua features include the following: Intermittent, semi-rhythmic, involuntary twitching involving a discrete subset of muscles Most commonly affects the face and ipsilateral distal hand musculature Myoclonus of this variety may evolve into partial or generalized convulsion Type II epilepsy partialis continua features include the following: Usually linked with Rasmussen encephalitis Gradual loss

2014 eMedicine Emergency Medicine

76. Status Epilepticus (Overview)

screening and anticonvulsant drug levels Arterial blood gas results Other tests that may be appropriate depending on the clinical setting include the following: Electroencephalography: Criterion standard for diagnosing status epilepticus [ , ] ; however, neurologic consultation is usually required Blood cultures Urinalysis and/or cerebrospinal fluid analysis Imaging studies Imaging modalities used to evaluate status epilepticus may include the following: CT scanning and/or MRI of the brain Chest (...) subdividing it into type I (nonprogressive) and type II (progressive). Type I epilepsy partialis continua features include the following: Intermittent, semi-rhythmic, involuntary twitching involving a discrete subset of muscles Most commonly affects the face and ipsilateral distal hand musculature Myoclonus of this variety may evolve into partial or generalized convulsion Type II epilepsy partialis continua features include the following: Usually linked with Rasmussen encephalitis Gradual loss

2014 eMedicine Emergency Medicine

77. Folotyn - pralatrexate

Developmental Therapeutics Program standard procedures. Of the 53 cancer cell lines tested, 36 cell lines (68%) were highly sensitive to the growth inhibitory effect of pralatrexate with GI50’s 30 ml/min might possibly be expected. ? Impaired hepatic function There was no specific study in patients with hepatic impairment. In the non-compartmental co-variate analysis, the laboratory markers Albumin, Bilirubin and Hb were not statistically significant co-variates for pralatrexate clearance. The range (...) function test m 2 square meter MALT mucosa-associated lymphoid tissue mg milligram min minute mL milliliter mos months MTD maximum tolerated dose NCI National Cancer Institute ND not determined NHL non-Hodgkin’s lymphoma NK natural killer NSAID nonsteroidal anti-inflammatory drug NSCLC non-small cell lung cancer OS overall survival PD progressive disease PDCO Paediatric Committee PET positron emission tomography PFS progression-free survival Folotyn CHMP assessment report Rev10.11 Page 7/85 Pgp P

2012 European Medicines Agency - EPARs

78. Pediatric Gastroesophageal Reflux Clinical Practice Guidelines

/University of British Columbia, Vancouver, BC, Canada, jj Department of Pediatrics, Upstate Medical University, Syracuse, NY, USA, Department of Pediatrics, University of Texas Health Sciences Center Houston and Shriners Hospital for Children, Houston, TX, USA, # Department of Pediatrics, University of Colorado Health Sciences Center, Denver, CO, USA, Department of Pediatrics, University of Naples ‘‘Federico II, ’’ Naples, Italy, {{ Centre for Paediatric Gastroenterology, Shef?eld Children’s Hospital (...) of gastroesophageal re?ux and gastroesophageal re?ux disease in the pediatric population. Conclusions: This document is intended to be used in daily practiceforthedevelopmentoffutureclinicalpracticeguidelines andas a basis forclinical trials. JPGN49:498–547, 2009.Key Words: Clinical practice guidelines—Diagnostic tests— Gastroesophageal re?ux (GER)—Gastroesophageal re?ux disease (GERD)—Therapeutic modalities. # 2009 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American

2009 North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition

79. CPG for the Management of Patients with Autism Spectrum Disorders in Primary Care

between 8-12 months, between 2-3 years and between 4-5 years old) as part of the monitoring of the healthy child D Health professionals should incorporate a high level of vigilance in the ? elds of social, play, language and behaviour development for the early identi? cation of ASD and related disorders In the monitoring of healthy child development in Primary Care, to help detect any developmental disorder, including ASD, it is recommended the use of scales (such as the Haizea Llevant scale (...) to illness) to consult the parents on concerns regarding their child’s development Professionals can use the items of the PEDS scale to direct questions about parental concerns (Appendix 5) Rating scales of suspected ASD C Population screening for ASDs is not recommended with the instruments developed at thismoment, although the capability of the M-CHAT and the Autonomous Scale is being investigated It has been 5 years since the publication of this Clinical Practice Guideline and it is subject

2009 GuiaSalud

80. A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome

tests, vital signs or ECG, as measured at Screening. QT/QTcF Exclusions (any of the following): QTcF > 450 msec. Three ECGs should be obtained at the time of Screening, 5 minutes apart from each other, and the results should be averaged. History of risk factors for torsade de pointes (e.g. heart failure, clinically significant hypokalemia or hypomagnesemia, or a family of long QT syndrome). A serum potassium at screening <3.0 mmol/L. QT/QTcF prolongation previously or currently controlled (...) with medication, in which normal QT/QTcF intervals could or can only be achieved with medication Current treatment with other medications that have demonstrated QT/QTc prolongation and have this risk described in the Warnings and Precautions section of their Prescribing Information Patients with significant hearing and/or visual impairments that may affect their ability to complete the test procedures. Current treatment with insulin Hgb A1C values outside of the normal reference range at Screening Current

2013 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>